Gassert, F.G.* et al. A deep learning model for classification of chondroid tumors on CT images. BMC Cancer 25:561 (2025)
Yin, H.* et al. Exploring FAM13A-N-Myc interactions to uncover potential targets in MYCN-amplified neuroblastoma: A study of protein interactions and molecular dynamics simulations. BMC Cancer 25:470 (2025)
Waltenberger, M.* et al. Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): Study protocol for a randomized phase III trial. BMC Cancer 23:709 (2023)
Ebert, K.* et al. Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies-the role of HAS2, SHB and HBEGF. BMC Cancer 22:254 (2022)
Manuelli, V.* et al. Invadopodia play a role in prostate cancer progression. BMC Cancer 22:386 (2022)
Voglhuber, T.* ; Eitz, K.A. ; Oechsner, M.* ; Vogel, M.M. & Combs, S.E. Analysis of using high-precision radiotherapy in the treatment of liver metastases regarding toxicity and survival. BMC Cancer 21:780 (2021)
Wenter, V.* et al. The diagnostic challenge of coexistent sarcoidosis and thyroid cancer - a retrospective study. BMC Cancer 21:139 (2021)
Aftahy, A.K.* et al. Intraventricular neuroepithelial tumors: Surgical outcome, technical considerations and review of literature. BMC Cancer 20:1060 (2020)
Devecka, M.* et al. Craniospinal irradiation(CSI) in patients with leptomeningeal metastases: Risk-benefit-profile and development of a prognostic score for decision making in the palliative setting. BMC Cancer 20:501 (2020)
Ebert, K.* et al. Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines (BMC Cancer, (2020), 20, 1, (1039), 10.1186/s12885-020-07540-7). BMC Cancer 20:1127 (2020)
Ebert, K.* et al. Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines. BMC Cancer 20:1039 (2020)
Kessel, K.A. et al. Stereotactic body radiotherapy (SBRT) in patients with lung metastases-prognostic factors and long-term survival using patient self-reported outcome (PRO). BMC Cancer 20:442 (2020)
Oehus, A.K.* et al. Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy. BMC Cancer 20:362 (2020)
Schmid, S.C.* et al. Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer - study protocol of a prospective, single arm, multicenter phase II trial (RACE IT). BMC Cancer 20:8 (2020)
Voglhuber, T.* et al. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases. BMC Cancer 20:536 (2020)
Borm, K.J.* et al. Outcomes of immediate oncoplastic surgery and adjuvant radiotherapy in breast cancer patients. BMC Cancer 19:907 (2019)
Dapper, H.* et al. Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelines. BMC Cancer 19:742 (2019)
Borm, K.J.* et al. Moving targets in 4D-CTs versus MIP and AIP: Comparison of patients data to phantom data. BMC Cancer 18:760 (2018)
Straube, C.* et al. Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma - the GlioCave study (NOA 17-ARO 2016/3-DKTK ROG trial). BMC Cancer 18:15 (2018)
Straube, C.* et al. A trend towards a more intense adjuvant treatment of low-grade-gliomas in tertiary centers in Germany after RTOG 9802-results from a multi-center survey. BMC Cancer 18:907 (2018)
Duma, M.N. ; Münch, S.* ; Oechsner, M.* & Combs, S.E. Are heart toxicities in breast cancer patients important for radiation oncologists? A practice pattern survey in German speaking countries. BMC Cancer 17:563 (2017)
Habl, G.* et al. Oligometastases from prostate cancer: Local treatment with stereotactic body radiotherapy (SBRT). BMC Cancer 17:361 (2017)
Keller, S.* et al. Evaluation of epidermal growth factor receptor signaling effects in gastric cancer cell lines by detailed motility-focused phenotypic characterization linked with molecular analysis. BMC Cancer 17:845 (2017)
Behrens, T.* et al. Occupational prestige, social mobility and the association with lung cancer in men. BMC Cancer 16:395 (2016)
Gross, E.* et al. Identification of BRCA1-like triple-negative breast cancers by quantitative multiplex-ligation-dependent probe amplification (MLPA) analysis of BRCA1-associated chromosomal regions: A validation study. BMC Cancer 16:811 (2016)
Higareda-Almaraz, J. et al. Systems-level effects of ectopic galectin-7 reconstitution in cervical cancer and its microenvironment. BMC Cancer 16:680 (2016)
Huber, M. et al. uPAR enhances malignant potential of triple-negative breast cancer by directly interacting with uPA and IGF1R. BMC Cancer 16:615 (2016)
Anastasov, N. et al. A 3D-microtissue-based phenotypic screening of radiation resistant tumor cells with synchronized chemotherapeutic treatment. BMC Cancer 15:466 (2015)
Evangelisti, C.* et al. A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors. BMC Cancer 15:157 (2015)
Roeper, B.* et al. Study of preoperative radiotherapy for sarcomas of the extremities with intensity-modulation, image-guidance and small safety-margins (PREMISS). BMC Cancer 15:904 (2015)
Rachner, T.D.* et al. High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients. BMC Cancer 14:649 (2014)
Frank, B.* et al. DNA repair gene polymorphisms and risk of chronic atrophic gastritis: A case-control study. BMC Cancer 11:440 (2011)
Luber, B.* et al. Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: Results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO). BMC Cancer 11:509 (2011)
Rauser, S. et al. High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma. BMC Cancer 10:608 (2010)
Zengel, P.* et al. Multimodal therapy for synergic inhibition of tumour cell invasion and tumour-induced angiogenesis. BMC Cancer 10:92 (2010)
Denzel, S. et al. Initial activation of EpCAM cleavage via cell-to-cell contact. BMC Cancer 9:402 (2009)
Langer, R.* ; Feith, M.* ; Siewert, J.R.* ; Wester, H.-J.* & Höfler, H. Expression and clinical significance of glucose regulated proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus. BMC Cancer 8:70 (2008)
Luettichau, I. et al. A complex pattern of chemokine receptor expression is seen in osteosarcoma. BMC Cancer 8:23 (2008)
Matthias, C.* ; Mack, B.* ; Berghaus, A.* & Gires, O. Keratin 8 expression in head and neck epithelia. BMC Cancer 8:267 (2008)
Mittelstraß, K. et al. Early onset lung cancer, cigarette smoking and the SNP309 of the murine double minute-2 (MDM2) gene. BMC Cancer 8:113 (2008)
Rosenberger, A.* et al. Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 years. BMC Cancer 8:60 (2008)
Nöckel, J.* et al. Characterization of gastric adenocarcinoma cell lines established from CEA424/SV40 T antigen-transgenic mice with or without a human CEA transgene. BMC Cancer 6:57 (2006)